A detailed history of Caption Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Caption Management, LLC holds 230,000 shares of DXCM stock, worth $18.4 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
230,000
Previous 130,000 76.92%
Holding current value
$18.4 Million
Previous $14.7 Million 4.58%
% of portfolio
0.27%
Previous 0.24%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $1.31 Million - $1.67 Million
11,900 New
11,900 $1.35 Million
Q3 2023

Nov 14, 2023

SELL
$86.06 - $137.93 $1.12 Million - $1.8 Million
-13,064 Reduced 87.09%
1,936 $180,000
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $1.46 Million - $1.72 Million
14,028 Added 1443.21%
15,000 $1.74 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $82,600 - $119,235
972 New
972 $110,000
Q1 2022

May 13, 2022

BUY
$94.08 - $130.2 $830,161 - $1.15 Million
8,824 Added 446.56%
10,800 $5.53 Million
Q4 2021

Feb 11, 2022

SELL
$129.87 - $162.82 $2.44 Million - $3.05 Million
-18,750 Reduced 90.47%
1,976 $1.06 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $1.63 Million - $2.01 Million
19,226 Added 1281.73%
20,726 $7.45 Million
Q4 2020

Feb 16, 2021

BUY
$78.0 - $104.5 $62,400 - $83,600
800 Added 114.29%
1,500 $554,000
Q3 2020

Nov 16, 2020

SELL
$95.51 - $112.95 $21,394 - $25,300
-224 Reduced 24.24%
700 $287,000
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $57,916 - $97,334
924 New
924 $376,000
Q1 2020

May 15, 2020

SELL
$47.79 - $75.63 $768,558 - $1.22 Million
-16,082 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$36.62 - $57.29 $588,922 - $921,337
16,082 New
16,082 $3.52 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.